185 related articles for article (PubMed ID: 2649286)
1. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
Ljunggren K; Karlson A; Fenyö EM; Jondal M
Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
3. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
Jewett A; Giorgi JV; Bonavida B
J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women.
Battle-Miller K; Eby CA; Landay AL; Cohen MH; Sha BE; Baum LL
J Infect Dis; 2002 Feb; 185(4):439-47. PubMed ID: 11865395
[TBL] [Abstract][Full Text] [Related]
8. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.
Ljunggren K; Broliden PA; Morfeldt-Månson L; Jondal M; Wahren B
Clin Exp Immunol; 1988 Sep; 73(3):343-7. PubMed ID: 3208446
[TBL] [Abstract][Full Text] [Related]
9. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults.
Jenkins M; Mills J; Kohl S
Pediatr Res; 1993 May; 33(5):469-74. PubMed ID: 8511019
[TBL] [Abstract][Full Text] [Related]
11. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Ahmad A; Ladha A; Cohen EA; Menezes J
Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
[TBL] [Abstract][Full Text] [Related]
12. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cell-mediated cytotoxicity can protect PBMC from infection by cell-associated HIV-1.
Hildreth JE; Hampton R; Halsey NA
Clin Immunol; 1999 Feb; 90(2):203-12. PubMed ID: 10080832
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
Nair MP; Schwartz SA
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
[TBL] [Abstract][Full Text] [Related]
15. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody.
Sirianni MC; Mezzaroma I; Aiuti F; Moretta A
Eur J Immunol; 1994 Aug; 24(8):1874-8. PubMed ID: 8056046
[TBL] [Abstract][Full Text] [Related]
17. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.
Ahmad A; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474
[TBL] [Abstract][Full Text] [Related]
18. Anti-class II antibodies in AIDS patients and AIDS-risk groups.
de la Barrera S; Fainboim L; Lugo S; Picchio GR; Muchinik GR; de Bracco MM
Immunology; 1987 Dec; 62(4):599-604. PubMed ID: 3501399
[TBL] [Abstract][Full Text] [Related]
19. [Natural killer (NK) activity in patients with HIV infection].
Ortona L; Tamburrini E; Tumbarello M; Ventura G; Cauda R
Boll Ist Sieroter Milan; 1988; 67(2):135-41. PubMed ID: 3228497
[TBL] [Abstract][Full Text] [Related]
20. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo.
Kohl S; Loo LS; Schmalstieg FS; Anderson DC
J Immunol; 1986 Sep; 137(5):1688-94. PubMed ID: 3528287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
